We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EYDAP:ATHEXAthens Water Supply and Sewerage Company S.A. Analysis

Data as of 2026-03-17 - not real-time

€8.71

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at €8.71, comfortably above its 20‑day SMA of 8.17 and 50‑day SMA of 7.71, indicating a short‑term uptrend. Momentum is strong with an RSI of 67, well below the overbought threshold. The MACD line sits at 0.30 above its signal at 0.24, generating a bullish histogram. Price is holding above the identified support of 7.31 while the nearest resistance sits near 8.72. Volume has been increasing, supporting the price advance. The beta of only 0.12 suggests minimal correlation with broader market moves, yet the 30‑day volatility of 59 % signals pronounced price swings.
However, a discounted cash‑flow model values the company at roughly €5.14, implying the market is trading about 17 % above intrinsic value. The dividend yield of 0.81 % with a modest payout ratio of 7 % is comfortably covered by cash balances and low debt. Operating margins are negative and free cash flow is currently a deficit, which tempers the attractiveness of the current price. The regulated water sector in Greece provides stable revenue but carries medium regulatory risk and country‑specific economic exposure. Liquidity is a concern, as daily trading volume (~69 k) is far below the 10‑day average of 1.3 M, placing the stock in a high liquidity‑risk bucket. Overall, the technical picture is bullish in the near term, but valuation and cash‑flow constraints suggest a cautious stance, with the dividend offering the primary upside for longer‑horizon investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (SMA, RSI, MACD)
  • Price above support and near resistance
  • Valuation premium to DCF

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable regulated revenue stream
  • Sustainable dividend yield
  • Negative operating margins limiting upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Low beta and defensive sector positioning
  • Potential price correction toward intrinsic value
  • Long‑term dividend income

Key Metrics & Analysis

Financial Health

Revenue Growth-0.70%
Profit Margin-0.27%
ROE-0.12%
ROA-1.13%
Debt/Equity0.75
P/B Ratio1.1
Op. Cash Flow€29.6M
Free Cash Flow€-40656376
Industry P/E23.4

Technical Analysis

TrendBullish
RSI67.1
Support€7.31
Resistance€8.72
MA 20€8.17
MA 50€7.71
MA 200€7.00
MACDBullish
VolumeIncreasing
Fear & Greed Index79.45

Valuation

Fair Value€5.14
Target Price€10.20
Upside/Downside17.11%
GradeOvervalued
TypeValue
Dividend Yield0.81%

Risk Assessment

Beta0.12
Volatility59.31%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.